Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-16 Purchase | 2026-10-19 7:47 pm | Iambic Therapeutics Inc. | IAM | Rachlin Evan Lockwood Director | 718,750 | $16 | $11,500,000 | 57,754 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-16 Conversion | 2026-10-19 8:20 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Catalio Capital Management LP Catalio Nexus Fund III LP Catalio Access Fund VIII LLC Catalio BH SPV LLC Petrocheilos George C 10% Owner | 6,192,334 | $0 | 742,546 (Indirect) | View |
| 2026-10-16 Conversion | 2026-10-19 7:53 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Vogelstein R Jacob Director | 6,192,334 | $0 | 742,546 (Indirect) | View |
| 2026-10-16 Conversion | 2026-10-19 7:51 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Secora Michael CFO & Chief Corp Dev Ofcr | 61,342 | $0 | 279,902 (Direct) | View |
| 2026-10-16 Conversion | 2026-10-19 7:49 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | RASTETTER WILLIAM H Chairperson of the Board | 393,499 | $0 | 200,920 (Indirect) | View |
| 2026-10-16 Conversion | 2026-10-19 7:47 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Rachlin Evan Lockwood Director | 3,385,988 | $0 | 57,754 (Indirect) | View |
| 2026-10-14 Option Award | 2026-10-16 4:27 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | EMSTER KURT VON Director | 20,300 | $0 | 20,300 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:26 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Vogelstein R Jacob Director 10% Owner | 20,300 | $0 | 20,300 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:24 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | TAGLIAFERRI MARY Director | 20,300 | $0 | 20,300 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:22 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Sharp Shalini Director | 20,300 | $0 | 20,300 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:21 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | RASTETTER WILLIAM H Chairperson of the Board | 40,600 | $0 | 40,600 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:19 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Rachlin Evan Lockwood Director | 20,300 | $0 | 20,300 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:16 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Secora Michael CFO & Chief Corp Dev Ofcr | 198,700 | $0 | 388,860 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:14 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Olson Peter A Chief Scientific Officer | 136,400 | $0 | 147,809 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:12 pm | N/A 2034-10-14 | Iambic Therapeutics Inc. | IAM | Josephson Neil Chief Medical Officer | 216,900 | $0 | 257,359 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:09 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Manby Frederick R Chief Technology Officer | 925,400 | $0 | 2,655,865 (Direct) | View |
| 2026-10-14 Option Award | 2026-10-16 4:07 pm | N/A 2036-10-14 | Iambic Therapeutics Inc. | IAM | Miller Thomas F. Chief Executive Officer | 925,400 | $0 | 2,203,956 (Direct) | View |
Ownership | 2026-10-14 8:40 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Catalio Capital Management LP Catalio Nexus Fund III LP Catalio Access Fund VIII LLC Catalio BH SPV LLC Petrocheilos George C 10% Owner | 0 | $0 | 4,196,585 (Indirect) | View |
Ownership | 2026-10-14 6:51 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Vogelstein R Jacob Director 10% Owner | 0 | $0 | 4,196,585 (Indirect) | View |
Ownership | 2026-10-14 6:50 pm | N/A 2034-08-26 | Iambic Therapeutics Inc. | IAM | TAGLIAFERRI MARY Director | 0 | $0 | 66,556 (Direct) | View |
Ownership | 2026-10-14 6:48 pm | N/A 2035-12-02 | Iambic Therapeutics Inc. | IAM | Sharp Shalini Director | 0 | $0 | 66,556 (Direct) | View |
Ownership | 2026-10-14 6:45 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | RASTETTER WILLIAM H Chairperson of the Board | 0 | $0 | 267,476 (Indirect) | View |
Ownership | 2026-10-14 6:43 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Rachlin Evan Lockwood Director | 0 | $0 | 1,927,252 (Indirect) | View |
Ownership | 2026-10-14 6:41 pm | N/A 2036-08-31 | Iambic Therapeutics Inc. | IAM | Hirawat Samit Director | 0 | $0 | 66,556 (Direct) | View |
Ownership | 2026-10-14 6:40 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Secora Michael CFO & Chief Corp Dev Ofcr | 0 | $0 | 451,171 (Direct) | View |
Ownership | 2026-10-14 6:38 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Olson Peter A Chief Scientific Officer | 0 | $0 | 273,039 (Direct) | View |
Ownership | 2026-10-14 6:34 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Josephson Neil Chief Medical Officer | 0 | $0 | 273,040 (Direct) | View |
Ownership | 2026-10-14 6:32 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Manby Frederick R Chief Technology Officer | 0 | $0 | 2,498,360 (Direct) | View |
Ownership | 2026-10-14 6:30 pm | N/A N/A | Iambic Therapeutics Inc. | IAM | Miller Thomas F. Chief Executive Officer | 0 | $0 | 1,927,877 (Direct) | View |